Regencell Bioscience Ltd (RGC) - Rasio kapitalisasi marang bathi resik
The absence of market barriers and early-stage testing create risks, however, Regencell Bioscience (RGC) will see profit growth through the sale of natural remedies for ADHD and autism. The company's average P/E reflects valuation payback dynamics, where the current level is -237.80. The strategy is based on implementing traditional Chinese medicine as an eco-friendly alternative to synthetic drugs for patients with neurodevelopmental disorders.
Rincian metrik komprehensif lan analitis Regencell (RGC)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- data nilai buku modal saham:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Regencell Bioscience|RGC - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Regencell Corp|RGC - Utang perusahaan|Rasio utang marang kapitalisasi buku Regencell Bioscience Holdings Limited|RGC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Regencell Bioscience|Rasio jangkoan perantara regencellbioscience.com
- data bathi bisnis lan rasio investasi:
RGC - Bathi resik|Bathi sing dikarepake Regencell Bioscience|RGC - Pangali P/E|Kapitalisasi marang proyeksi bathi Regencell Bioscience Ltd|RGC - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Regencell Bioscience Holdings Limited|RGC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Regencell Bioscience|RGC - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan regencellbioscience.com|RGC - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Regencell Bioscience
Analisis komprehensif perusahaan:regencellbioscience.com
The P/E ratio reflects the market value of one unit of net profit, allowing an investor to determine the degree of overpayment for an asset by comparing quotes with the business's actual earnings. When analyzing the P/E ratio of Regencell Bioscience (RGC), one should consider the commercialization potential of drugs for treating neurological disorders, as future payouts from Asian insurance funds may justify the current fundamental value of the business.
Analisis perusahaan pesaing
Kapitalisasi marang bathi biogen.com BIIB|Pangali P/E NBIX|Axsome (AXSM) - Rasio kapitalisasi marang bathi resik|Pangali P/E ACAD (ACADIA Pharmaceuticals Inc)|Xenon Corp (XENE) - Kapitalisasi marang bathi|VKTX - Rasio rega marang bathi|SUPN (supernus.com) - Pangali rega marang bathi|CPRX: Pangali P/E|Koefisien rega marang bathi Denali|HRMY (Harmony Pharma) - Pangali P/E|Kapitalisasi marang bathi Biohaven Corp BHVN|Rasio rega marang bathi Amylyx Pharmaceuticals (AMLX)|Rasio rega marang bathi TRVI (trevitherapeutics.com)|Rasio rega marang bathi Praxis Precision Medicines, Inc. PRAX|Anavex - Rasio rega marang bathi|CBLL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|ALEC: Pangali P/E|ANNX (annexonbio.com) - Rasio rega marang bathi|OMER (Omeros Corp) - Pangali P/E|Neurogene Inc (NGNE) - Periode bali modal bisnis|Rasio rega marang bathi AC Immune Corp (ACIU)|VYGR - Kapitalisasi marang bathi|Rasio rega marang bathi Neumora Therapeutics NMRA|Periode bali modal bisnis scilexholding.com (SCLX)|Tevogen Bio - Pangali P/E|Alpha Cognition (ACOG) - Koefisien rega marang bathi|CGTX: Pangali P/E|IKT - Periode bali modal bisnis|SAVA (Cassava Sciences, Inc.) - Pangali P/E|Kapitalisasi marang bathi Assertio Therapeutics ASRT|Rasio rega marang bathi Coya Therapeutics, Inc. (COYA)|vistagen.com - Pangali rega marang bathi|Pangali P/E OVID (Ovid Therapeutics)|ABOS - Koefisien rega marang bathi|CervoMed Inc. - Pangali P/E|Kapitalisasi marang bathi Alterity Therapeutics|clene.com (CLNN) - Rasio rega marang bathi|PepGen - Nilai perusahaan marang bathi resik|JUNS (Jupiter Neurosciences) - Pangali P/E|RLMD - Rasio kapitalisasi marang bathi resik|Pangali P/E ANVS|Koefisien rega marang bathi gracetx.com GRCE|Rasio rega marang bathi Firefly Neuroscience AIFF|KLTO: Pangali rega marang bathi|NeuroSense Therapeutics, Ltd. - Pangali P/E|Kapitalisasi marang bathi Reviva Pharmaceuticals, Inc.|MTVA (metaviatx.com) - Koefisien rega marang bathi|neuraxis.com (NRXS) - Pangali P/E|Rasio rega marang bathi Helius Medical Technologies, Inc.|PASG: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|NERV - Kapitalisasi marang bathi|Rasio rega marang bathi Athira Pharma, Inc. ATHA|Nilai perusahaan marang bathi resik ADXN|Alzamend - Pangali P/E|Kapitalisasi marang bathi Cyclerion Therapeutics|PTIX: Pangali P/E|Rasio kapitalisasi marang bathi resik Pasithea Therapeutics Corp. KTTA|CRGT (Cortigent Inc) - Pangali P/E|Kapitalisasi marang bathi avenuetx.com ATXI|Rasio rega marang bathi BrainStorm Cell Therapeutics (BCLI)|Cara Therapeutics Inc. - Pangali rega marang bathi|Pangali P/E CHRO (Chromocell Therapeutics Corporation)|ELYM - Koefisien rega marang bathi|Intra-Cellular - Pangali P/E|Kapitalisasi marang bathi longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|NKGN (NKGen Biotech Inc) - Rasio rega marang bathi|Rasio rega marang bathi NeuroBo|Rasio rega marang bathi SAGE|Koefisien rega marang bathi SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|anewmeds.com - Rasio rega marang bathi|Cerevel - Pangali P/E
